Accumulation of CD8+T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope-Reference-Cited by-同舟云学术

Accumulation of CD8+T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope

Published:2006-06-19 Issue:1 Volume:177 Page:255-267
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Ryan Christina M.,Schell Todd D.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Strategies for immunotherapy of cancer

2. Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

3. MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING

4. Human tumor antigens recognized by T lymphocytes.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study;Vaccines;2023-03-13

2. Imnuno-Oncología: Recuento Histórico y Fundamentos Básicos.;Oncología (Ecuador);2018-04-30

3. Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes;Clinical & Translational Immunology;2017-10-20

4. PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination;The Journal of Immunology;2017-09-22

5. Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+T Cells;The Journal of Immunology;2012-11-21